The aim of this study was to determine prevalence of smokers and ex-smokers in the older diabetes population in Europe and to evaluate the relationship with various sociodemographic and lifestyle risk factors. This epidemiological study used Wave 8 of the multidisciplinary and cross-national SHARE database, which includes cross-sectional data on health, socio-economic status and social and family networks of individuals aged 50 and over from 27 European countries. Among the 6,903 participants with diabetes, 12.2% were current smokers, 29.9% were former smokers and 57.9% had never smoked. Among countries' diabetes populations, the highest prevalence of ex-smokers (57.6%) with a low prevalence of smokers (9.5%) was seen in the Netherlands. The highest prevalence of never-smokers (84.2%) was found in Latvia, with the lowest prevalence of ex-smokers (7.9%). Austria had the highest prevalence of current smokers (17.9%) along with a below-average prevalence of ex-smokers (26.5%) was seen in Austria. Normal weight, being overweight, lower education, living without a partner, living in larger cities, drinking alcohol in the last 7 days, lower age, and being male were associated with a higher risk of being a current smoker. The study shows high prevalence of smoking among the older diabetes population in Europe and provides data on the association of smoking with several risk factors and country-specific differences in smoking prevalence.

Department of Internal Medicine 2nd Faculty of Medicine Charles University University Hospital Motol 5 Úvalu 84 Prague 150 00 Czech Republic

Department of Primary Care 2nd Faculty of Medicine University Hospital Motol 5 Úvalu 84 Prague 150 00 Czech Republic

Department of Social Geography and Regional Development Faculty of Science Charles University Albertov 6 Prague 128 00 Czech Republic

National Institute of Public Health Šrobárova 48 Prague 100 00 Czech Republic

Zobrazit více v PubMed

Medical Research Council’s statement on tobacco smoking and cancer of the lung. Lancet272, 1345–1347 10.1016/S0140-6736(57)91865-2 (1957). PubMed

GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 397, 2337–2360; (2021). 10.1016/S0140-6736(21)01169-7 Erratum in: Lancet. 397, 2336 (2021). PubMed PMC

World Health Organization. WHO global report on trends in prevalence of tobacco use 2000–2025, 4th ed. World Health Organization. (2021). https://apps.who.int/iris/handle/10665/348537

Śliwińska-Mossoń, M. & Milnerowicz, H. The impact of smoking on the development of diabetes and its complications. Diab Vasc Dis. Res.14, 265–276. 10.1177/1479164117701876 (2017). PubMed

Godsland, I. F. & Walton, C. Insulin resistance and cigarette smoking. Lancet340, 607. 10.1016/0140-6736(92)92138-6 (1992). PubMed

Harris, K. K., Zopey, M. & Friedman, T. C. Metabolic effects of smoking cessation. Nat. Rev. Endocrinol.12, 299–308. 10.1038/nrendo.2016.32 (2016). Erratum in: Nat Rev Endocrinol. 12, 684 (2016). PubMed

Durlach, V. et al. Smoking and diabetes interplay: A comprehensive review and joint statement. Diabetes Metab.48, 101370. 10.1016/j.diabet.2022.101370 (2022). PubMed

Davies, M. J. et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 45, 2753–2786. 10.2337/dci22-0034 (2022). PubMed PMC

Börsch-Supan, A. Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 8. Release Version: 8.0.0 (SHARE-ERIC, 2022). 10.6103/SHARE.w8.800

Bergmann, M. & Börsch-Supan, A. (eds) SHARE Wave 8 Methodology: Collecting Cross-National Survey Data in Times of COVID-19 (MEA, Max Planck Institute for Social Law and Social Policy, 2021).

Börsch-Supan, A. et al. Data resource profile: the survey of health, ageing and retirement in Europe (SHARE). Int. J. Epidemiol.10.1093/ije/dyt088 (2013). PubMed PMC

UNESCO Institute for Statistics. International Standard Classification of Education. ISCED (2011). 10.15220/978-92-9189-123-8-en, (UIS, 2012).

OECD/European Union. Diabetes prevalence, in Health at a Glance: Europe 2020: State of Health in the EU Cycle. 10.1787/83231356-en (OECD Publishing, (2020).

World Health Organization. Regional Office for Europe. European Tobacco Use: Trends Report 2019 (World Health Organization Regional Office for Europe, 2019). https://apps.who.int/iris/handle/10665/346817

Smoking of tobacco products by. sex, age and degree of urbanisation. EUROSTAT [online], last updated 27 Oct 2022. https://ec.europa.eu/eurostat/databrowser/bookmark/70ccad07-7208-4b3e-b9b9-87bf2be6b9a3?lang=en&page=time:2019. (EUROSTAT, 2022).

Roderick, P., Turner, V., Readshaw, A., Dogar, O. & Siddiqi, K. The global prevalence of tobacco use in type 2 diabetes mellitus patients: A systematic review and meta-analysis. Diabetes Res. Clin. Pract.154, 52–65. 10.1016/j.diabres.2019.05.035 (2019). PubMed

Brož, J. et al. Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study. Diabetes Res. Clin. Pract.170, 108470. 10.1016/j.diabres.2020.108470 (2020). PubMed

Willi, C., Bodenmann, P., Ghali, W. A., Faris, P. D. & Cornuz, J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA298, 2654–2664. 10.1001/jama.298.22.2654 (2007). PubMed

Aubin, H. et al. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ345, e4439. 10.1136/bmj.e4439 (2012). PubMed PMC

Komiyama, M. et al. Analysis of factors that determine weight gain during smoking cessation therapy. PLoS One. 8, e72010. 10.1371/journal.pone.0072010 (2013). PubMed PMC

Harris, K. K., Zopey, M. & Friedman, T. C. Metabolic effects of smoking cessation. Nat. Rev. Endocrinol.12, 299–308. 10.1038/nrendo.2016.32 (2016). PubMed PMC

Willemsen, M. C., Mons, U. & Fernández, E. Tobacco control in Europe: progress and key challenges. Tob. Control. 31, 160–163. 10.1136/tobaccocontrol-2021-056857 (2022). PubMed

World Health Organization. WHO report on the global tobacco epidemic. : protect people from tobacco smoke. (2023). https://apps.who.int/iris/handle/10665/372043 (World Health Organization, 2023).

Bar-Zeev, Y. et al. Tobacco legislation reform and industry response in Israel. Tob. Control. 30, e62–e64. 10.1136/tobaccocontrol-2020-056041 (2021). PubMed PMC

Rosen, L. et al. Historic tobacco legislation in Israel: a moment to celebrate. Isr. J. Health Policy Res.910.1186/s13584-020-00384-3 (2020). PubMed PMC

Rey-Brandariz, J. et al. Evolution of smoking prevalence in Spain and its 17 autonomous regions Evolución de la prevalencia de consumo de tabaco en España y sus 17 comunidades autónomas (1987–2020). Medicina clinica. 162, 417–424; (1987–2020). 10.1016/j.medcli.2023.11.015 (2024). PubMed